Articles Referencing IART

Zacks.com

Bear of the Day: Integra LifeSciences (IART) - Bear of the Day

INTEGRA LIFESCI (IART): Free Stock Analysis Report ISHARES NDQ BIO (IBB): ETF Research Reports SPDR-HLTH CR (XLV): ETF Research Reports To read this article on Zacks.com click here. ... Read >>

Zacks.com

Disappointing 1Q Earnings for IART - Analyst Blog

Integra LifeSciences Holdings Corp. ( IART ) reported adjusted earnings per share (EPS) of 39 cents in the first quarter of 2013, declining 45.1% from the year-ago quarter, as well as below... Read >>

Zacks.com

Product Recall Plagues Integra - Analyst Blog

On Apr 10, 2013, musculoskeletal major Integra LifeSciences Holdings Corporation ( IART ) initiated a voluntary recall of some of its products manufactured during Dec 2010-May 2011 and Nov... Read >>

Zacks.com

Integra's Second Cobalt Chrome Rod - Analyst Blog

In line with its product pipeline expansion and development plan, recently musculoskeletal major - Integra LifeSciences Holdings Corporation ( IART ) launched the second cobalt chrome rod... Read >>

Zacks.com

FDA Nod for Integra's Extremity Offer - Analyst Blog

Medical products company - Integra LifeSciences ( IART ) recently received 510k clearance from the U.S. Food and Drug Administration (FDA) for its Proximal Humeral Fracture Plate System.... Read >>

Zacks.com

Integra Strong on Balanced Growth - Analyst Blog

Integra LifeSciences Holdings Corporation ( IART ) reported earnings per share ('EPS') of 46 cents in the fourth quarter of fiscal 2012, significantly up from 16 cents in the... Read >>

Zacks.com

Accuray's Outlook Disappoints - Analyst Blog

Radiosurgery systems maker, Accuray Incorporated ( ARAY ) announced preliminary results for the second quarter of fiscal 2013 as well as provided guidance for fiscal 2013. The company... Read >>

Kapitall

Medical Breakthrough: Successful Stem Cell Transplant in Sweden

Finding organ donors could soon be a thing of the past. The latest miracle of modern medicine allowed doctors to replace a man’s cancerous windpipe with a new man-made one, comprised of a... Read >>

Schaeffer's Investment Research

Opening View: DJIA Leaves April Behind, Looks to Higher Ground in May

The Dow Jones Industrial Average's ( DJIA ) eight-week winning streak came to an end last week, as a confluence of weak economic data, Goldman Sachs ( GS ) fallout, a massive oil spill... Read >>